Superficial CD34-positive fibroblastic tumor is an infrequent soft-tissue tumor characterized by a lesion located in the subcutaneous fascia without affecting the soft or deep muscle planes. Its incidence is unknown; therefore, it represents a diagnostic challenge for both the surgical oncologist and pathologist. Given its high risk of local recurrence, extensive surgical resection is the recommended treatment modality. This is the first report of this rare entity in Latin-America.
NLM Catalog Indexing
Radical Novelty of Research
NIH Funded Articles
- Objectively Coding Intervention Fidelity During A Phone-Based Obesity Prevention Study
- Acculturation and Subclinical Atherosclerosis among U.S. South Asians: Findings from the MASALA study
- Predictors of Obstructive Sleep Apnea Risk among Blacks with Metabolic Syndrome
- Wake-up Strokes Are Similar to Known-Onset Morning Strokes in Severity and Outcome
- Endothelial Cells May Have Tissue-Specific Origins
- Molecular Mechanism Linking BRCA1 Dysfunction to High Grade Serous Epithelial Ovarian Cancers with Peritoneal Permeability and Ascites
Annex PublishersAnnex publishers is an Open Access publication model which allows the publication of articles to the world through this community. We provide you the asset of interaction with the most researchers from the scientific community. Anyone can freely access the articles printed under Annex publishers.
Why Open Access?Open access provides an unlimited access to journals and publications, with a perfect platform for thousands of researchers to form jointly for the development of science. Open Access assists in accelerating the scientific discovery, encourage innovation, enhance education and refresh the economy to build up the knowledge of the general public.
A Selected Case of Achalasia Treated with Botulinum Toxin Case Presentation
There is presented intrasphincetric injection management of achalasia, an esophageal dysmotility disorder involving an abnormal relaxation of the lower esophageal sphincter. Botulinum toxin A is a well-described treatment for achalasia, in patients who is contraindicated others modality due to comorbidity, especially in older age. We describe a case of a successful treatment of achalasia in the 83-old man with botulinum toxin A, as efficacy and very safe method for symptomatic relieve of these patients.
Does Body Mass Index Influence the Onset and Prognosis of Colorectal Cancer?
Overweight and obesity are considered an increasing colorectal cancer risk factor. The association between excess body weight and colorectal cancer appears to be related to a state of systemic low-grade inflammation, due to an overproduction of proinflammatory cytokines.
Pediatric Teleneurology in the Time of the Pandamic; Favourable Out comes from Implementation of Telemedicine in Pedriatric Epilepsy and Autism Clinincs During the Covid-19 Pandemic